Literature DB >> 30741356

Innovating Cancer Care Delivery: the Example of the 4R Oncology Model for Colorectal Cancer Patients.

Julia Trosman1,2, Christine Weldon3,4, Sheetal Kircher4,5, William Gradishar4,5, Al Benson4,5.   

Abstract

OPINION STATEMENT: Care delivery innovation is necessary to address the growing complexity of cancer care across specialties and integrate new diagnostics, treatments, and services into care delivery. Informed by Cancer Care Delivery Research (CCDR), multilevel intervention research, and other disciplines, this article describes the 4-step cancer care delivery innovation cycle. The cycle guides collaborative efforts of cancer clinicians, researchers, patients, and other stakeholders to systematically define care delivery problems and formulate, test, and implement care innovations to effectively address problems. We illustrate the 4 steps of the innovation cycle with the example of developing the 4R Oncology Model for colorectal cancer (4R is Right Information and Right Care for the Right Patient at the Right Time). The 4R is a multilevel intervention informed by CCDR, the team science, and lessons learned from other models, such as survivorship care planning. We offer additional considerations for balancing the need to innovate with concerns about constrained resources and overextended workforce. We suggest to focus on care delivery models which are synergistic with other efforts and do not require extensive information systems support in earlier cycles of development.

Entities:  

Keywords:  4R Oncology Model; Cancer care delivery; Care delivery innovation; Care delivery models; Care delivery redesign; Project management in care delivery; Systems engineering in cancer care delivery

Mesh:

Year:  2019        PMID: 30741356     DOI: 10.1007/s11864-019-0608-7

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  58 in total

Review 1.  Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review.

Authors:  Linda Lee; Winson Y Cheung; Esther Atkinson; Monika K Krzyzanowska
Journal:  J Clin Oncol       Date:  2010-11-22       Impact factor: 44.544

2.  Redesigning Advanced Cancer Care Delivery: Three Ways to Create Higher Value Cancer Care.

Authors:  Manali I Patel; David Moore; Arnold Milstein
Journal:  J Oncol Pract       Date:  2015-05-19       Impact factor: 3.840

Review 3.  Survivorship Care Planning: Why Is It Taking So Long?

Authors:  Sarah A Birken; Deborah K Mayer
Journal:  J Natl Compr Canc Netw       Date:  2017-09       Impact factor: 11.908

Review 4.  Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis.

Authors:  Melissa J Edwards; Ian D Campbell; Ross A Lawrenson; Marion J Kuper-Hommel
Journal:  Breast Cancer Res Treat       Date:  2017-05-20       Impact factor: 4.872

5.  Achieving Coordinated Care for Patients With Complex Cases of Cancer: A Multiteam System Approach.

Authors:  Simon J Craddock Lee; Mark A Clark; John V Cox; Burton M Needles; Carole Seigel; Bijal A Balasubramanian
Journal:  J Oncol Pract       Date:  2016-10-31       Impact factor: 3.840

6.  Regional Multiteam Systems in Cancer Care Delivery.

Authors:  Katia Noyes; John R T Monson; Irfan Rizvi; Ann Savastano; James S A Green; Nick Sevdalis
Journal:  J Oncol Pract       Date:  2016-09-30       Impact factor: 3.840

Review 7.  Current practices and challenges of adjuvant chemotherapy in patients with colorectal cancer.

Authors:  Christine Brezden-Masley; Chanele Polenz
Journal:  Surg Oncol Clin N Am       Date:  2014-01       Impact factor: 3.495

8.  Burnout and career satisfaction among US oncologists.

Authors:  Tait D Shanafelt; William J Gradishar; Michael Kosty; Daniel Satele; Helen Chew; Leora Horn; Ben Clark; Amy E Hanley; Quyen Chu; John Pippen; Jeff Sloan; Marilyn Raymond
Journal:  J Clin Oncol       Date:  2014-01-27       Impact factor: 44.544

9.  The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium.

Authors:  Jasmin A Tiro; Aruna Kamineni; Theodore R Levin; Yingye Zheng; Joanne S Schottinger; Carolyn M Rutter; Douglas A Corley; Celette S Skinner; Jessica Chubak; Chyke A Doubeni; Ethan A Halm; Samir Gupta; Karen J Wernli; Carrie Klabunde
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-10       Impact factor: 4.254

Review 10.  Endocrine side effects of cancer immunotherapy.

Authors:  Priscilla Cukier; Fernando C Santini; Mariana Scaranti; Ana O Hoff
Journal:  Endocr Relat Cancer       Date:  2017-10-12       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.